急性缺血性卒中患者，推荐不用链激酶(1a级)。
For patients with acute ischemic stroke, we recommend against streptokinase (Grade 1a).
目的探讨脑急性缺血性卒中患者动脉内溶栓治疗的安全性和有效性。
Objective To evaluate the safety and efficacy of intra - arterial fibrinolysis for acute thrombosis of cerebral vessels.
对于急性缺血性卒中患者，推荐不用全量抗凝，静脉输注或皮下注射低分子量肝素或类肝素(1b级)。
For patients with acute ischemic stroke, we recommend against full-dose anticoagulation with IV, sc, or LMWHs or heparinoids (Grade 1b).
溶栓是治疗急性缺血性卒中的有效方法，但临床上仍可见溶栓后患者改善的神经功能不能得到有效维持。
Thrombolysis is the effective method in the treatment of AIS. However, the improvement of neurological function in some patients cannot be maintained after thrombolysis in clinical practice.
急性缺血性卒中的致残率很高，改善或维护患者的神经功能是治疗的最终目的。
The disability rate of acute ischemic stroke(AIS) is very high, improve and maintain neurological function is the ultimate objective.
急性缺血性卒中的致残率很高，改善或维护患者的神经功能是治疗的最终目的。
The disability rate of acute ischemic stroke(AIS) is very high, improve and maintain neurological function is the ultimate objective.
应用推荐